These data indicate that the quantity and intracellular location of Piwil2 expression is the key determinant for the progression of TICs to cancer cells, which parallels the histological progression of CIN lesions to malignant lesions. This evidence concerns the gene PIWIL2 and cervical squamous intraepithelial neoplasia.